HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China-Reference-Cited by-全球学者库

HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China

Published:2022-11 Issue: Volume:Volume 15 Page:6711-6722
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Li Qun,Yu Fengting,Song Chuan,Zhao Hongxin,Xiao Qing,Lao Xiaojie,Yang Siyuan,Tang Yunxia,Zhang Fujie

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference44 articles.

1. World Health Organization. HIV/AIDS; 2020. Available from: http://www.who.int/mediacentre/factsheets/fs360/en/. Accessed November 7, 2022.

2. Five-Year Outcomes of the China National Free Antiretroviral Treatment Program

3. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort

4. Persistent Low-Level Viremia is an Independent Risk Factor for Virologic Failure: A Retrospective Cohort Study in China

5. World Health Organization. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations. World Health Organization; 2016.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors;HIV Medicine;2023-11-22

2. Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011–2022: A Retrospective Study;Infection and Drug Resistance;2023-07

3. From Capillary Electrophoresis to Deep Sequencing: An Improved HIV-1 Drug Resistance Assessment Solution Using In Vitro Diagnostic (IVD) Assays and Software;Viruses;2023-02-19